The role of IFN-γ in systemic lupus erythematosus:: a challenge to the Th1/Th2 paradigm in autoimmunity

被引:168
作者
Theofilopoulos, AN [1 ]
Koundouris, S [1 ]
Kono, DH [1 ]
Lawson, BR [1 ]
机构
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
关键词
cytokines; IFN-gamma; lupus; Th1; Th2;
D O I
10.1186/ar290
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The classification of T helper cells into type 1 (Th1) and type 2 (Th2) led to the hypothesis that Th1 cells and their cytokines (interleukin [IL]-2, interferon [IFN]-gamma) are involved in cell-mediated autoimmune diseases, and that Th2 cells and their cytokines (IL-4, IL-5, IL-10, IL-13) are involved in autoantibody( humoral)-mediated autoimmune diseases. However, this paradigm has been refuted by recent studies in several induced and spontaneous mouse models of systemic lupus erythematosus, which showed that IFN-gamma is a major effector molecule in this disease. These and additional findings, reviewed here, suggest that these two cross-talking classes of cytokines can exert autoimmune disease-promoting or disease-inhibiting effects without predictability or strict adherence to the Th1-versus-Th2 dualism.
引用
收藏
页码:136 / 141
页数:6
相关论文
共 68 条
[31]   Complexity or coherence? Cytokine secretion by B cells [J].
Mosmann, T .
NATURE IMMUNOLOGY, 2000, 1 (06) :465-466
[32]  
MOSMANN TR, 1986, J IMMUNOL, V136, P2348
[33]   Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice [J].
Mueller, R ;
Krahl, T ;
Sarvetnick, N .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) :1093-1099
[34]   THE BASIC SCIENCE OF GENE-THERAPY [J].
MULLIGAN, RC .
SCIENCE, 1993, 260 (5110) :926-932
[35]   INVIVO CYTOKINE GENE-EXPRESSION IN T-CELL SUBSETS OF THE AUTOIMMUNE MRL/MP-LPR/LPR MOUSE [J].
MURRAY, LJ ;
LEE, R ;
MARTENS, C .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (01) :163-170
[36]  
Nakajima A, 1997, J IMMUNOL, V158, P1466
[37]   The combination of polymorphisms within interferon-γ receptor 1 and receptor 2 associated with the risk of systemic lupus erythematosus [J].
Nakashima, H ;
Inoue, H ;
Akahoshi, M ;
Tanaka, Y ;
Yamaoka, K ;
Ogami, E ;
Nagano, S ;
Arinobu, Y ;
Niiro, H ;
Otsuka, T ;
Niho, Y .
FEBS LETTERS, 1999, 453 (1-2) :187-190
[38]   INVIVO TREATMENT WITH A MONOCLONAL-ANTIBODY TO INTERFERON-GAMMA NEITHER AFFECTS THE SURVIVAL NOR THE INCIDENCE OF LUPUS-NEPHRITIS IN THE MRL/LPR-LPR MOUSE [J].
NICOLETTI, F ;
MERONI, P ;
DIMARCO, R ;
BARCELLINI, W ;
BORGHI, MO ;
GARIGLIO, M ;
MATTINA, A ;
GRASSO, S ;
LANDOLFO, S .
IMMUNOPHARMACOLOGY, 1992, 24 (01) :11-16
[39]   Systemic delivery of interleukin 10 by intramuscular injection of expression plasmid DNA prevents autoimmune diabetes in nonobese diabetic mice [J].
Nitta, Y ;
Tashiro, F ;
Tokui, M ;
Shimada, A ;
Takei, I ;
Tabayashi, K ;
Miyazaki, J .
HUMAN GENE THERAPY, 1998, 9 (12) :1701-1707
[40]   Cytokines induce the development of functionally heterogeneous T helper cell subsets [J].
O'Garra, A .
IMMUNITY, 1998, 8 (03) :275-283